Zika Vaccine Development Strategies for Emergency Preparedness Raman Rao Takeda Vaccines Pte LTD, Singapore
The Zika virus outbreaks have highlighted the need for the development of an effective vaccine especially in dealing with outbreak or emergency response. There are however, significant challenges in evaluating the efficacy of such vaccines and delivering them from a manufacturing standpoint to meet such situations. Innovative platforms are being considered for product development and solutions to determine the efficacy of the vaccine to ensure licensure of the product. Takeda Vaccines Inc has embarked on the development of a safe and effective Purified Inactivated Zika Vaccine to support global health and addressing emergency preparedness.
Credits
Credits: None available.
You must be logged in and own this product in order to post comments.